Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mark Schiebler
University of California, San Francisco, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Healthmyne
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Mechanism of mucus pathology in asthma exacerbations
Asthma exacerbations are a major public health problem, and mucus contributes significantly to the pathogens of asthma exacerbations. Available mucolytics have significant limitations of cost and convenience that restrict their application in practice. Or project proposes to address an unmet need for a well-tolerated and easily delivered mucolytic drug whose target of disulfide linkages make it relevant to diseases associated with heightened oxidative stress, including acute severe asthma.
Filed on July 25, 2019.
Tell us what you know about Mark Schiebler's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Mark Schiebler”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mark Schiebler | University of California, San Francisco | Conflict of Interest | Stemina Biomarkers | $0 - $4,999 |
| Mark Schiebler | University of California, San Francisco | Conflict of Interest | X-vax | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.